MedCity News March 7, 2023
WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy. The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million.
Weight loss and weight management company WeightWatchers announced Monday that it will acquire subscription telehealth platform Sequence, allowing the company to move into the chronic weight management space.
The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million.
New York City-based WeightWatchers is a wellness company that combines technology and...
Today's Sponsors
Today's Sponsor